Invention Grant
- Patent Title: Method of treating cancer with an anti-CCR8 that binds tumor infiltrating cells
-
Application No.: US17134775Application Date: 2020-12-28
-
Publication No.: US11932696B2Publication Date: 2024-03-19
- Inventor: Tetsuya Yoshida , Yujiro Kidani , Mitsunobu Matsumoto , Takayuki Kanazawa , Satomi Shinonome , Kanji Hojo , Naganari Ohkura , Shimon Sakaguchi , Atsushi Tanaka , Hisashi Wada , Atsunari Kawashima , Norio Nonomura
- Applicant: Shionogi & Co., Ltd. , Osaka University
- Applicant Address: JP Osaka
- Assignee: SHIONOGI & CO., LTD.,OSAKA UNIVERSITY
- Current Assignee: SHIONOGI & CO., LTD.,OSAKA UNIVERSITY
- Current Assignee Address: JP Osaka; JP Osaka
- Agency: Morgan, Lewis & Bockius LLP
- Priority: JP 17065603 2017.03.29 JP 17185935 2017.09.27
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K9/00 ; A61K35/17 ; A61K39/00 ; A61K47/60 ; A61K47/64 ; A61K47/68 ; A61P35/00 ; G01N33/50
Abstract:
The present invention provides a pharmaceutical composition for cancer treatment comprising an antibody against CCR8.
Public/Granted literature
- US20210115148A1 Pharmaceutical Composition for Cancer Treatment Public/Granted day:2021-04-22
Information query
